1.
Bauer DE, Pai S-Y. Getting Past HSC Security: Cyclosporine H Gives Lentiviruses an Entry Pass. Cell Stem Cell. 2018;23(6):775-776. doi:10.1016/j.stem.2018.11.008.
1.
He YJ, Meghani K, Caron M-C, et al. DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells. Nature. 2018;563(7732):522-526. doi:10.1038/s41586-018-0670-5.
1.
Demas AR, Sharma AI, Wong W, et al. Mutations in actin-binding protein coronin confer reduced artemisinin susceptibility. Proc Natl Acad Sci U S A. 2018;115(50):12799-12804. doi:10.1073/pnas.1812317115.
1.
Lee HK, Willi M, Miller SM, et al. Targeting fidelity of adenine and cytosine base editors in mouse embryos. Nat Commun. 2018;9(1):4804. doi:10.1038/s41467-018-07322-7.
1.
Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet. 2018;19(12):770-788. doi:10.1038/s41576-018-0059-1.
1.
Raj B, Gagnon JA, Schier AF. Large-scale reconstruction of cell lineages using single-cell readout of transcriptomes and CRISPR-Cas9 barcodes by scGESTALT. Nat Protoc. 2018;13(11):2685-2713. doi:10.1038/s41596-018-0058-x.
1.
Chen PJ, Hussmann JA, Yan J, et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 2021;184(22):5635-5652.e29. doi:10.1016/j.cell.2021.09.018.
1.
Nishimasu H, Shi X, Ishiguro S, et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science. 2018;361(6408):1259-1262. doi:10.1126/science.aas9129.
1.
Xiong T, Meister GE, Workman RE, et al. Targeted DNA methylation in human cells using engineered dCas9-methyltransferases. Sci Rep. 2017;7(1):6732. doi:10.1038/s41598-017-06757-0.
1.
Weidmann AG, Choudhary A. Special Issue on the Chemical Biology of CRISPR. ACS Chem Biol. 2018;13(2):283-284. doi:10.1021/acschembio.8b00134.